# Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers

> **NCT01166555** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04236921

## Key facts

- **NCT ID:** NCT01166555
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166555, "Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01166555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*